Skip to main content

Recognition of Large-Scale ncRNA Data Using a Novel Multitask Cross-Learning 0-Order TSK Fuzzy Classifier

Buy Article:

$107.14 + tax (Refund Policy)

Recognizing noncoding ribonucleic acid (ncRNA) data is helpful in realizing the regulation of tumor formation and certain aspects of life mechanisms, such as growth, differentiation, development, and immunity. However, the scale of ncRNA data is usually very large. Using machine learning (ML) methods to automatically analyze these data can obtain more precise results than manually analyzing these data, but the traditional ML algorithms can process only small-scale training data. To solve this problem, a novel multitask cross-learning 0-order Takagi–Sugeno–Kang fuzzy classifier (MT-CL-0-TSK-FC) is proposed that uses a multitask cross-learning mechanism to solve the large-scale learning problem of ncRNA data. In addition, the proposed MT-CL-0-TSK-FC method naturally inherits the interpretability of traditional fuzzy systems and eventually generates an interpretable rulesbased database to recognize the ncRNA data. The experimental results indicate that the proposed MT-CL-0TSK-FC method has a faster running time and better classification accuracy than traditional ML methods.

Keywords: LARGE-SCALE DATA; MULTITASK LEARNING; NONCODING RIBONUCLEIC ACID; TSK FUZZY CLASSIFIER

Document Type: Research Article

Publication date: 01 February 2020

More about this publication?
  • Journal of Medical Imaging and Health Informatics (JMIHI) is a medium to disseminate novel experimental and theoretical research results in the field of biomedicine, biology, clinical, rehabilitation engineering, medical image processing, bio-computing, D2H2, and other health related areas.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content